Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    October 25-26, 2022

    Annual Summit on Material, Polymer Science and Engineering

    Budapest, Hungary
    October 28-29, 2022

    2nd World Summit on Emerging Materials and Nanotechnology

    Amsterdam, Netherlands
    November 24-25, 2022

    16th Annual Conference on Stem Cell and Biomaterials

    Amsterdam, Netherlands
    December 01-02, 2022

    42nd Global Conference on Smart Materials and Nanotechnology

    Amsterdam, Netherlands
    December 05-06, 2022

    International Conference on Materials Processing

    London, UK
    December 05-06, 2022

    World Summit on Sustainable Materials

    London, UK
    January 09-10, 2023

    World Summit on Data Science and Machine Learning

    London, UK
    April 12-13, 2023

    6th European Meeting on Materials Science and Nanotechnology

    Zurich, Switzerland
    April 21-22, 2023

    27th Materials Science and Nano Tech Expo

    Paris, France

    Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in